A new voice in the drug delivery market emerges with the launch of Drug Delivery Business News
In the years since we launched MassDevice.com our audience has always wanted to know if there was another market we were looking at and we often were a little stymied at the question. After all, the medical device industry is so robust and provides so much news on a daily basis we didn’t feel it necessary to branch off.
However, since 2015 and the merger with WTWH Media we’ve been growing our medical offerings dramatically, namely the launch of Medical Design & Outsourcing, which has become a fixture in the industry already in just 15 months or so. So, we turned our sights to another market, drug delivery and combination products.
The drug delivery and combination products world sits at the intersection of the three most powerful forces in healthcare: biotech, medical device and pharma. Estimates from some leading research firms suggest that the global market for combination products could reach $144 billion by 2017 and is growing at a nearly 6% CAGR, making it a no brainer for us to cover.
So what do we consider drug delivery? In as simple a thought as I can come up with its any medical product that carries, elutes or is coated with a pharmaceutical or biological agent. This is a broad world, we know, since basically I’ve just described everything from a bandaid to bone cement, or inhalers to chemotherapy.
It’s a tall task but we’re up to the challenge. We’ve hired a terrific young editor Sarah Faulkner, who has a degree in chemistry and journalism and is straight out of our alma mater Boston University’s College of Communication. And, we have the blueprint, which we’ve developed in turning MassDevice.com from a fledgling start up to the anchor of a news organization that brings in more than 100,000 readers monthly.
Here’s what you can expect over the next few months. We’ll be posting 5-7 original pieces of content on the drug delivery/combination products industry over the coming months as we create our new email newsletter “The Pipeline.” This grace period will allow us to help Sarah establish a voice, connect the dots on the biggest players in the market and work out the kinks in the site. In the interim, we’ll be mastering the inner workings of the industry and reaching out to the movers and shakers.
Further, we’re looking to our readers to help educate us on what we need to get up to speed here. If you have thoughts or want to give us a tip, hit up the contact here.
That’s all for us, we hope you’ll bookmark drugdeliverybusiness.com and sign up for our newsletter.
Publisher, Medical Platform